← back to search

Jingying Li

University of Fribourg ·
🔎 Find collaborators in Molecular Biology · Pulmonary and Respiratory Medicine →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Molecular Biology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Cancer research, Glioma, Immunotherapy, Medicine, Biology, and Immune system.
h-index
citations
503
works
24
NIH funding
primary concept
email

Recent publications

FBXL16 regulates TAMs recruitment by mediating cytokine release in gliomas
Cancer Genetics 2025cited by 1position: middledoi
The link between neutrophils, NETs, and NLRP3 inflammasomes: The dual effect of CD177 and its therapeutic potential in acute respiratory distress syndrome/acute lung injury
Biomolecules and Biomedicine 2024cited by 16position: firstdoi
DNMT3A promotes glioma growth and malignancy via TNF-α/NF-κB signaling pathway
Translational Cancer Research 2024cited by 9position: middledoi
Endosome-microautophagy targeting chimera (eMIATAC) for targeted proteins degradation and enhance CAR-T cell anti-tumor therapy
Theranostics 2024cited by 4position: middledoi
Pan-cancer analysis: predictive role of TAP1 in cancer prognosis and response to immunotherapy
BMC Cancer 2023cited by 29position: middledoi
Protein disulfide-isomerase A4 confers glioblastoma angiogenesis promotion capacity and resistance to anti-angiogenic therapy
Journal of Experimental & Clinical Cancer Research 2023cited by 15position: middledoi
Predictive role of E2F6 in cancer prognosis and responses of immunotherapy
International Immunopharmacology 2023cited by 5position: middledoi
Identification of a robust scoring system based on metabolic genes followed by in-depth validation of ATP1A3 in glioma
Life Sciences 2023cited by 4position: lastdoi
The effect of soil environmental factors on the yield and quality of Pueraria lobata
Scientific Reports 2023cited by 4position: middledoi
Ferroptosis in tumor immunity and therapy
Journal of Cellular and Molecular Medicine 2022cited by 50position: middledoi
Protein Disulfide-Isomerase A3 Is a Robust Prognostic Biomarker for Cancers and Predicts the Immunotherapy Response Effectively
Frontiers in Immunology 2022cited by 41position: middledoi
CLCF1 Is a Novel Potential Immune-Related Target With Predictive Value for Prognosis and Immunotherapy Response in Glioma
Frontiers in Immunology 2022cited by 23position: lastdoi
Sperm Autoantigenic Protein 17 Predicts the Prognosis and the Immunotherapy Response of Cancers: A Pan-Cancer Analysis
Frontiers in Immunology 2022cited by 14position: middledoi
Immune Characteristics and Prognosis Analysis of the Proteasome 20S Subunit Beta 9 in Lower-Grade Gliomas
Frontiers in Oncology 2022cited by 9position: middledoi
Comprehensive analysis of the prognostic implications and functional exploration of PAK gene family in human cancer
Cancer Cell International 2022cited by 9position: middledoi
Transcriptional Patterns of Lower‐Grade Glioma Patients with Distinct Ferroptosis Levels, Immunotherapy Response, and Temozolomide Sensitivity
Oxidative Medicine and Cellular Longevity 2022cited by 8position: middledoi
Development and validation of a leukocyte‐associated immunoglobulin‐like receptor‐1 prognostic signature for lower‐grade gliomas
Cancer Medicine 2022cited by 3position: middledoi
Macropinocytosis: mechanism and targeted therapy in cancers.
PubMed 2021cited by 39position: middle
Identification of an epithelial-mesenchymal transition related long non-coding RNA (LncRNA) signature in Glioma
Bioengineered 2021cited by 26position: middledoi
Human Mitochondrial Ribosomal RNA Modification-Based Classification Contributes to Discriminate the Prognosis and Immunotherapy Response of Glioma Patients
Frontiers in Immunology 2021cited by 7position: middledoi
Systematic and Multi-Omics Prognostic Analysis of Lysine Acetylation Regulators in Glioma
Frontiers in Molecular Biosciences 2021cited by 5position: middledoi
FABP4 inhibitors suppress inflammation and oxidative stress in murine and cell models of acute lung injury
Biochemical and Biophysical Research Communications 2018cited by 43position: middledoi
Blockage of glycolysis by targeting PFKFB3 alleviates sepsis-related acute lung injury via suppressing inflammation and apoptosis of alveolar epithelial cells
Biochemical and Biophysical Research Communications 2017cited by 100position: middledoi
Inhibition of NEDD4 inhibits cell growth and invasion and induces cell apoptosis in bladder cancer cells
Cell Cycle 2017cited by 39position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Kai Huang · Nanchang University16 papers (2021–2023)Zewei Tu · Nanchang University14 papers (2021–2024)Lei Wu · Guangzhou University of Chinese Medicine10 papers (2021–2025)Xiaoyan Long · Nanchang University9 papers (2022–2024)Xingen Zhu · Nanchang University9 papers (2021–2024)Junzhe Liu · Nanchang University7 papers (2022–2024)Xingen Zhu · Nanchang University7 papers (2021–2023)Qiankun Ji · Nanchang University6 papers (2022–2024)Kunjian Lei · Nanchang University5 papers (2022–2024)Shigang Lv · Nanchang University5 papers (2021–2024)Chuandong Gong · Nanchang University4 papers (2022–2024)Zhansheng Fang · Nanchang University4 papers (2022–2025)Minhua Ye · Jiangxi Mental Health Center4 papers (2021–2024)Miaojing Wu · Nanchang University3 papers (2022–2025)Miaojing Wu · Nanchang University3 papers (2021–2022)Chuming Tao · Nanchang University3 papers (2021–2023)Lufei Yang · Nanchang University2 papers (2022–2024)Zhu Xingen · Nanchang University2 papers (2022–2025)Yuanqi Gong · Nanchang University2 papers (2017–2018)Min Luo · Fudan University Shanghai Cancer Center2 papers (2022–2023)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Molecular Biology · Pulmonary and Respiratory Medicine →